- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Endosonics extends deal with Cordis
Intravascular ultrasound (IVUS) developer Endosonics of Pleasanton,CA, has extended its product distribution relationship with Cordis.The deal gives Cordis, of Miami Lake, FL, exclusive distributionrights in North America and Europe to Endosonics IVUS
Intravascular ultrasound (IVUS) developer Endosonics of Pleasanton,CA, has extended its product distribution relationship with Cordis.The deal gives Cordis, of Miami Lake, FL, exclusive distributionrights in North America and Europe to Endosonics IVUS productsfor coronary applications. Cordis has agreed to provide fundingfor joint product development programs and made a $5 million equityinvestment in Endosonics.
Endosonics in January reported year-end financial results thatshowed revenues more than doubling, to $17.1 million from $8 millionin 1994. Its loss for the year narrowed, to $10.5 million comparedwith $13.3 million in 1994.
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.
